(Q27852211)
English
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
scientific article
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Statements
2 references
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study (English)
Keith Wilner
Yael P Mossé
Stephan D Voss
Katherine Ruffner
Julie Laliberte
Delphine Rolland
Brenda J Weigel
Ashish M Ingle
Charlotte Ahern
Peter C Adamson
Susan M Blaney
Identifiers
2 references
2 references
2 references